Firefly Neuroscience (AIFF) Convertible Debt (2024)
Firefly Neuroscience (AIFF) posted Convertible Debt of $694000.0 for Q4 2024.
Powered by 
Analysis
Firefly Neuroscience (AIFF) Convertible Debt (2024) Analysis & Trends
Firefly Neuroscience has reported Convertible Debt for 1 years, with the latest figure at $694000.0 in Q4 2024.
- On a quarterly basis, Convertible Debt changed N/A year-over-year to $694000.0 in Q4 2024; TTM through Dec 2024 was $694000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $694000.0, changed N/A from the prior year.
- Convertible Debt was $694000.0 for Q4 2024 at Firefly Neuroscience.
- The five-year high for Convertible Debt was $694000.0 in Q4 2024, with the low at $694000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 |